SEC filing · 8-K

Bolt Biotherapeutics, Inc.: Material agreement

Bolt Biotherapeutics amended its facility lease to accelerate the expiration date and reduce ongoing rent obligations.

Filed October 6, 2026

Mixed for the company

What happened

On October 1, 2026, the company entered into a second lease amendment with landlord HCP LS Redwood City LLC.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Bolt Biotherapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.